ISIN | CH0271797448 |
---|---|
Valor Number | 27179744 |
Bloomberg Global ID | VAKSFUH SW |
Fund Name | VVA - Aktien Schweiz F (USD hedged) |
Fund Provider |
UBS Switzerland AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Other Funds |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 182.58 USD | 01.04.2025 |
---|---|---|
Previous Price * | 181.43 USD | 31.03.2025 |
52 Week High * | 187.04 USD | 20.03.2025 |
52 Week Low * | 153.43 USD | 16.04.2024 |
NAV * | 182.58 USD | 01.04.2025 |
Issue Price * | 182.58 USD | 01.04.2025 |
Redemption Price * | 182.58 USD | 01.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 2,079,810,960 | |
Unit/Share Assets *** | 5,615,578 | |
Trading Information SIX |
YTD Performance | +11.57% |
31.12.2024 - 01.04.2025
31.12.2024 01.04.2025 |
---|---|---|
YTD Performance (in CHF) | +8.58% |
31.12.2024 - 01.04.2025
31.12.2024 01.04.2025 |
1 month | -2.23% |
03.03.2025 - 01.04.2025
03.03.2025 01.04.2025 |
3 months | +11.38% |
03.01.2025 - 01.04.2025
03.01.2025 01.04.2025 |
6 months | +7.71% |
01.10.2024 - 01.04.2025
01.10.2024 01.04.2025 |
1 year | +15.81% |
02.04.2024 - 01.04.2025
02.04.2024 01.04.2025 |
2 years | +27.50% |
03.04.2023 - 01.04.2025
03.04.2023 01.04.2025 |
3 years | +22.67% |
01.04.2022 - 01.04.2025
01.04.2022 01.04.2025 |
5 years | +66.03% |
01.04.2020 - 01.04.2025
01.04.2020 01.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SWISS MKT IX FUTR Mar25 | 6.30% | |
---|---|---|
Novartis AG Registered Shares | 5.75% | |
Roche Holding AG | 4.49% | |
Nestle SA | 3.86% | |
Zurich Insurance Group AG | 2.97% | |
ABB Ltd | 2.55% | |
Compagnie Financiere Richemont SA Class A | 2.51% | |
Holcim Ltd | 2.04% | |
Alcon Inc | 1.51% | |
Lonza Group Ltd | 1.33% | |
Last data update | 28.02.2025 |
TER | 0.53% |
---|---|
TER date | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.50% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |